Two days Conference of Chief Commissioners/Pr. Commissioners of Central Excise
Two days Conference of Chief Commissioners/Pr. Commissioners of Central
Excise in Chandigarh concludes; resolves most of the issues to bring-out
certainty in assessment, uniformity in practice across the country and clarity
in understanding the legal issues.
A two days conference of Chief
Commissioners/Principal Commissioners of Central Excise was held in Chandigarh
on 28th and 29th of October, 2015 with Member (Central Excise), Central Board
of Excise and Customs chairing the conference. Chief Commissioners/Principal
Commissioners from across the country attended the conference. The conference
deliberated on a large number of issues relating to Central Excise law
affecting the manufacturers of goods. The conference resolved most of the
issues to bring out certainty in assessment, uniformity in practice across the
country and clarity in understanding the legal issues.
It is expected that the resolution of such large number of technical issues in Central Excise taxation would reduce litigation and improve ease of doing business. The conference also identified issues where further simplification of business processes needs to be carried out to augment the efforts of the Government towards “Make in India” campaign.
************
Government Approves Sixteen (16) Proposals of Foreign Direct Investment
(FDI) Amounting to Rs. 4,722 Crore Approximately
Based on the recommendations of Foreign
Investment Promotion Board in its meeting held on 29th September
2015, the Government has approved 16 (sixteen) proposals of Foreign Direct
Investment amounting to Rs. 4,722 crore.
The following 16 (Sixteen) proposals have been approved:
Sl. No.
|
Item No.
|
Name of
the applicant
|
Gist of the proposal
|
Sector
|
FDI
|
1
|
1
|
M/s Sun Pharma Research Advanced Company Limited
|
Approval sought to offer, issue and allot equity shares to FIIs, FPIs,
NRIs and OCBs, pursuant to the Proposed Rights Issue, whether by way of
renunciation or otherwise, upto an aggregate amount of ` 250 crore in the
proposed rights issue of the company.
|
Pharma
|
250 crores
|
2
|
2
|
M/s Schulke India Pvt. Ltd.
|
Accepting transfer of local assets as part of a global acquisition
agreement entered into between M/s Schulke GMBH and Advanced Sterilization
Products (ASP) Division of Ethicon, Inc., a subsidiary of Johnson &
Johnson Services Inc.
|
Pharma
|
76.2 crore
|
3
|
4
|
M/s Synergia Life Sciences Pvt. Ltd.
|
Approval to accept investment by M/s India Life Sciences Fund II LLC by
subscribing to 428,725 equity shares of Rs. 10 each at a premium of Rs. 923
per share under private placement, constituting 30% of the share capital on a
fully diluted basis.
|
Pharma
|
Rs 40 crore
|
4
|
5
|
M/s Strides Arcolab Limited
|
Approval has been sought for issuing shares to non-resident and resident
equity shareholders of M/s Shasun Pharmaceuticals Limited under a scheme of
merger
|
Pharma
|
nil(merger)
|
5
|
7
|
M/s MMI Strategic Investments (Pty) Ltd.
|
Approval sought for foreign Investment of 49% percent in an Indian health
insurance company by subscribing to 4,92,16,177 equity shares of the company
for INR 1,96,27,50,000.
|
Insurance
|
196 crores
|
6
|
8
|
M/s Safran Engineering Services India Private Limited
|
Approval has been sought for deletion of conditions in the last FIPB
approval dated 03.02.2010
|
Services related to Defence Sector
|
nil
|
7
|
13
|
M/s Multi Screen Media Private Limited
|
Approval sought for deletion of Clause 7(b) of the FIPB Approval
|
Broadcasting
|
nil
|
8
|
16
|
M/s IVF Trustee Company
|
approval of the FIPB for the proposed investments by Indium V and
Cayman Fund of upto ` 2,880 million (approximately US$ 45 million) and `
3,200 million (approximately US$ 50 million) respectively in units of IVF
V.
|
Venture Capital Fund (AIF)
|
608 crores
|
9
|
18
|
M/s International Trade and Exhibitions India Private Limited
|
Approval for proposed expansion of the scope of its business activities
in printing, publishing and circulating or otherwise, dealing in all types of
Books, scientific and technical magazines/ specialty journals/ periodicals
and other publications but not in any manner dealing with news and current
affairs.
|
Print
Media
|
nil
|
10
|
19
|
M/s Aditya Birla Nuvo
|
post facto approval for the issue of convertible warrants to
M/s Surya Kiran Investments Pte Ltd., Singapore, on February 21, 2008.
|
Misc.
|
Rs 377 crores
|
11
|
20
|
M/s Energy City Navi Mumbai Holding Company
|
Post-facto approval for the transfer of Equity shares of Fully
& Compulsorily Convertible Debentures (CCDs) in Valuable Properties
Private Limited by the applicant to its WoS i.e. VTMPL.
|
Construction and Development
|
Rs 139 crors (already brought in )
|
12
|
22
|
M/s Gulf Packaging Machines JLT
|
Approval for setting up LLP.
|
LLP
|
Rs 0.65 crores
|
13
|
23
|
M/s Blue Star Infotech Limited
|
approval sought for issuance of ESOPs to non-resident shareholders
|
IT/ITES
|
nil
|
14
|
24
|
M/s HDFC Capital Advisors Limited
|
Approval sought for issue of units to M/s Green Light A 2014 Trust. HDFC
Fund proposes to make investments in equity, equity linked instruments,
redeemable preference shares, non-convertible debentures and other debt
securities of listed or unlisted investee companies engaged in real estate
construction development projects which are permitted under the SEBI AIF
Regulations as a Category II AIF.
|
Venture
Capital Fund (AIF)
|
2400 crore
|
15
|
26
|
M/s Indian Herbs Specialities Private Limited
|
Approval for receiving FDI by the way of fresh subscription to
shares and purchase of shares by the Investor from the existing shareholders
to be issued to India 2020 Fund II, Limited
|
Pharma
|
75 crores
|
16
|
27
|
M/s AEGON RELIGARE LIFE INSURANCE COMPANY LIMITED
|
Approval sought for the transfer of shares of the company held by
Bennett, Coleman & Company to AEGON India Holding B.V thereby raising
the foreign shareholding from 26% to 49%.
|
Insurance
|
559.96 crores
|
The following 6(six) proposals have been deferred:
Sl. No.
|
Item No.
|
Name of the applicant
|
Gist of the proposal
|
Sector
|
1
|
9
|
M/s BF Elbit Advanced Systems Private Limited
|
Approval has been sought for increasing the foreign shareholding
from 26% to 49% by its existing shareholder
|
Defence
|
2
|
17
|
M/s Sharekhan Limited
|
Post facto approval for carrying on the commodities brokerage business
through subsidiary and the depository services business by itself while there
was investment made by foreign investors from time to time in Sharekhan.
II. Investment in Sharekhan by IDFC since IDFC was regarded as a foreign owned company from March 2011 till March 2014 III. Investment in Human Value Developers Private Limited by IDFC since IDFC was regarded as a foreign owned company from March 2011 till March 2014 and IV. Downstream investment made by Human Value Developers Private Limited in 2007 in M/s Sharekhan |
NBFC
|
3
|
21
|
M/s Serap India Pvt. Ltd.
|
Permission for issue of equity shares to with a premium of Rs. 10
per share against total outstanding dues of Rs. 11,47,64,901 towards purchase
of capital goods, components and raw material from them and condonation of
delay of 1215 days in applying for such permission.
|
Manufacturing
|
4
|
25
|
M/s Reliance Globalcom Ltd., Bermuda
|
Approval sought to purchase M/s GCX India Ltd., an Indian owned and
controlled company
|
Telecom
|
5
|
29 &30
|
M/s Taurus Ventures Limited and M/s Capricorn Ventures Limited
|
Proposal 1:
M/s Taurus Ventures Limited has sought approval, for the issuance of
shares to the shareholders of Max India pursuant to the Scheme and to have
foreign shareholding of 37.08% (NRI’s / OCBs - 0.99% FDI - 12.14% FIIs
- 23.95%).
Proposal 2:
M/s Capricorn Ventures Limited has sought approval to have foreign
shareholding for the issuance of shares to the shareholders of Max India
pursuant to the Scheme and to have foreign shareholding of 37.08%
(NRI’s / OCBs - 0.99% FDI - 12.14% FIIs - 23.95%).
|
Miscellaneous(Demerger)
|
The
following 08 (eight) proposals have been rejected:
Sl. No.
|
Item No.
|
Name of the applicant
|
Gist of the proposal
|
Sector
|
1
|
6
|
M/s Cipla Health Limited (yet to be incorporated)
|
Approval sought for (i) Initial investment of `1,06,00,00,000 from
FIL Capital Investments (Mauritius) II Limited in M/s Cipla Health Limited
(yet to incorporated), by way of subscription to fresh equity shares and
compulsory convertible preference shares up to a maximum of 26.11% of the
share capital of Cipla Health limited, in the process of being incorporated
by Cipla Limited
(ii) Subsequent Investment of upto ` 15,66,00,000 by FIL Capital Investments (Mauritius) II Limited in subsequent rounds of Investment in a public limited company (i.e. Cipla Health Limited) in the process of being incorporated by Cipla Limited post the closing of the Initial Investment. |
Pharma
|
2
|
10
|
M/s Menon Bearings Limited
|
Approval sought to enter defence production. They are currently involved
in automobile related manufacturing.
|
Defence
|
3
|
11
|
M/s DW Animation Ireland Limited, Ireland
|
Approval for setting up of an LLP in India with FDI of (i) ` 99,980
amounting to ~ US $ 1,587 contributing 99.98% of the capita of LLP by DW
Animation Ireland Limited; and (ii) `10 amounting to - USD 0.16 contributing
0.01% of the capital of LLP by Robert Alan Kelly.
|
LLP
|
4
|
12
|
M/s Atria Convergence Technologies Private Limited,
|
Approval for 100% transfer of shares from existing shareholdersto
new Foreign Investors Argan (Mauritius) Limited ("Argan") and TA
FVCI Investors Limited ("TA FVCI")
|
Telecom and Broadcasting
|
5
|
14
|
M/s Vadatech India Private Limited
|
Permission to account all the expenses incurred prior to its
incorporation and its bank account opening and to issue Equity shares at par,
against amount transferred by M/s Vadatech Inc. USA, to the professional firm
i.e. M/s. Navin Nayak & Associates.
|
LLP
|
6
|
15
|
M/s Meshlabs Software Private Limited,
|
permission for Conversion of the Company [having FDI and NRI
holding of 22% into Limited LLP
|
LLP
|
7
|
28
|
APOLLO Hospitals Enterprise Limited
|
Approval has been sought by APOLLO Hospitals Enterprise Limited for
allowing foreign investment in the share capital of the Company by the
renunciation of the rights or otherwise, subject to RBI and other necessary
approvals to residents outside India pursuant to the proposed Rights Issue.
|
Pharma, Healthcare and Insurance
|
8
|
31
|
ii5 Technologies Pvt ltd
|
ii5 Technologies Pvt ltd having 99.997% of foreign investment by ii5
Ventures Ltd , Singapore has applied for conversion of the existing Private
Limited company to LLP.
|
LLP
|
1 (one) proposal does not lie before FIPB:
Sl. No.
|
Item No.
|
Name of the applicant
|
Gist of the proposal
|
Sector
|
1
|
3
|
M/s Shilpa Medicare Limited
|
Permitting FIIs and other Foreign Investors to acquire/ hold equity
shares of the Company up to an aggregate limit of 30% of the paid up equity
share capital.
|
Pharma
|
*************
Taxation of income from off-shore Rupee Denominated Bonds
The Reserve Bank of India has recently permitted
Indian corporates to issue rupee denominated bonds outside India.
The matter of taxation of income from such bonds under Income-tax Act, 1961 has been considered by the Government.
In so far as taxation of interest income from these INR off-shore bonds in the case of non-resident investors is concerned, it is clarified that withholding tax at the rate of 5 percent, which is in the nature of final tax, would be applicable in the same way as it is applicable for off-shore dollar denominated bonds.
Further, it has been decided that the Capital gains, arising in case of appreciation of rupee between the date of Issue and the date of redemption against the foreign currency in which the investment is made, would be exempted from capital gains tax. Legislative amendment in this regard will be proposed through the Finance Bill, 2016.
The matter of taxation of income from such bonds under Income-tax Act, 1961 has been considered by the Government.
In so far as taxation of interest income from these INR off-shore bonds in the case of non-resident investors is concerned, it is clarified that withholding tax at the rate of 5 percent, which is in the nature of final tax, would be applicable in the same way as it is applicable for off-shore dollar denominated bonds.
Further, it has been decided that the Capital gains, arising in case of appreciation of rupee between the date of Issue and the date of redemption against the foreign currency in which the investment is made, would be exempted from capital gains tax. Legislative amendment in this regard will be proposed through the Finance Bill, 2016.
Post a Comment